They promote tumor growth by remodeling the ECM to facilitate invasion, secreting pro-tumorigenic factors such as IL-6 and neuregulin 1 (NRG1) that enhance proliferation and therapy resistance, as well as fostering an immunosuppressive “cold” microenvironment. Here, IL6 is linked to neoplasm.